Hypofibrinogenaemia in metastatic carcinoma of the prostate: suppression of systemic fibrinolysis by haparin.
D000347:Afibrinogenemia / Q000188:drug therapy / Q000209:etiology*; D000368:Aged; D001780:Blood Coagulation Tests; D002277:Carcinoma / Q000150:complications*; D004903:Erythrocyte Aggregation / Q000150:complications; D005342:Fibrinolysis / Q000187:drug effects; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis; D011471:Prostatic Neoplasms / Q000150:complications*
D006493:Heparin